GEC-ESTRO ACROP prostate brachytherapy guidelines
This is an evidence-based guideline for prostate brachytherapy. Throughout levels of
evidence quoted are those from the Oxford Centre for Evidence based Medicine …
evidence quoted are those from the Oxford Centre for Evidence based Medicine …
[HTML][HTML] Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique
S Vaggers, BP Rai, ECP Chedgy, A de la Taille… - World Journal of …, 2021 - Springer
Introduction Radiation dose to the rectum in prostate brachytherapy (PBT) can be reduced
by the use of polyethylene glycol (PEG) hydrogel spacers. This reduces the rate of rectal …
by the use of polyethylene glycol (PEG) hydrogel spacers. This reduces the rate of rectal …
COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation
Purpose The purpose of this study was to highlight the importance of timely brachytherapy
treatment for patients with gynecologic, breast, and prostate malignancies, and provide a …
treatment for patients with gynecologic, breast, and prostate malignancies, and provide a …
Ultrahypofractionation should be a standard of care option for intermediate-risk prostate cancer
A Loblaw - Clinical Oncology, 2020 - Elsevier
Conclusion UHF using older technology has been shown in one large RCT to be non-
inferior to conventionally fractionated EBRT for failure-free survival and equal in terms of late …
inferior to conventionally fractionated EBRT for failure-free survival and equal in terms of late …
Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: late toxicity and patient reported outcomes from a randomized phase II clinical trial
M Corkum, A Loblaw, Y Hasan, HT Chung… - Radiotherapy and …, 2021 - Elsevier
Abstract Background and Purpose Long-term toxicity of high dose-rate brachytherapy as
monotherapy for prostate cancer is not well defined. We report late toxicity and health …
monotherapy for prostate cancer is not well defined. We report late toxicity and health …
Prostate cancer brachytherapy: SFRO guidelines 2021
P Pommier, M Ferré, P Blanchard, É Martin… - Cancer …, 2022 - Elsevier
Prostate brachytherapy techniques are described, concerning both permanent seed implant
and high dose rate brachytherapy. The following guidelines are presented: brachytherapy …
and high dose rate brachytherapy. The following guidelines are presented: brachytherapy …
[HTML][HTML] Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
M Moll, A Renner, C Kirisits, C Paschen… - Strahlentherapie und …, 2021 - Springer
Purpose This study's objective was the comparison of external beam radiotherapy (EBRT)
and I‑125 seed brachytherapy regarding clinical outcome and development of side effects …
and I‑125 seed brachytherapy regarding clinical outcome and development of side effects …
Complications and side effects of high-dose-rate prostate brachytherapy
K Martell, MA Kollmeier - Brachytherapy, 2021 - Elsevier
Purpose To describe technical challenges and complications encountered during and after
high-dose-rate prostate brachytherapy (HDR-BT) and review management of these …
high-dose-rate prostate brachytherapy (HDR-BT) and review management of these …
Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters
J Poder, A Howie, R Brown, J Bucci… - Radiotherapy and …, 2020 - Elsevier
Purpose To compare the dose measured by MOSkin dosimeters coupled to a trans-rectal
ultrasound (TRUS) probe to the dose predicted by the brachytherapy treatment planning …
ultrasound (TRUS) probe to the dose predicted by the brachytherapy treatment planning …
High dose rate brachytherapy in high-risk localised disease–why do anything else?
GC Morton, SM Alrashidi - Clinical Oncology, 2020 - Elsevier
The management of high-risk prostate cancer is challenging, as patients have a high risk of
both local and distant relapse. Although adjuvant systemic treatment remains an important …
both local and distant relapse. Although adjuvant systemic treatment remains an important …